首頁 > 市場調查報告書 > 醫療設備

導管

消融設備市場規模、佔有率和成長分析（按技術、應用、最終用戶和地區分類）—產業預測，2026-2033年

市場調查報告書

商品編碼

1895578

消融設備市場規模、佔有率和成長分析（按技術、應用、最終用戶和地區分類）—產業預測，2026-2033年

Ablation Devices Market Size, Share, and Growth Analysis, By Technology (Radiofrequency Devices, Laser/Light Ablation), By Application (Cardiology, Oncology), By End-user, By Region-Industry Forecast 2026-2033

出版日期: 2025年12月15日 | 出版商:

SkyQuest | 英文 192 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球消融設備市場規模將達到 104.2 億美元，到 2025 年將達到 115.6 億美元，到 2033 年將達到 264.4 億美元，預測期（2026-2033 年）的複合年成長率為 10.9%。

全球消融設備市場正經歷顯著成長，這主要得益於癌症和心血管疾病等慢性疾病發生率的上升，以及對微創手術需求的不斷成長。這些用途廣泛的設備被應用於心臟病學、腫瘤學、婦科和泌尿系統等多個醫療領域，推動了市場規模的擴大。射頻消融、微波消融、冷凍消融和雷射消融等消融技術的不斷進步，提高了手術效率和患者療效，與傳統手術相比，患者恢復更快，併發症更少。此外，醫療基礎設施的完善、醫療支出的增加以及患者對創新治療方案認知度的提高，也推動了市場的發展。然而，設備和手術的高成本構成了挑戰，尤其對於新興市場的小規模醫療機構而言，這阻礙了消融技術的廣泛應用。

消融設備市場按技術、應用、最終用戶和地區進行細分。依技術分類，可分為電磁波療法、雷射/光消融設備、超音波設備、冷凍消融設備和其他技術。依應用分類，可分為心臟病學、腫瘤學、眼科、婦科學、泌尿系統科學、整形外科和其他應用。依最終用戶分類，可分為醫院、門診手術中心和其他最終用戶。依地區分類，可分為北美、亞太、歐洲、拉丁美洲以及中東和非洲。

全球消融設備市場成長要素

癌症、心血管疾病和神經系統疾病等慢性病的日益普遍是推動全球消融設備市場成長的主要因素。隨著患者和醫療機構擴大選擇非侵入性和微創治療方法，消融技術在心房顫動、肝腫瘤和脊椎疾病等疾病治療的應用也日益增多。這一趨勢在老年患者中尤其明顯，他們面臨更高的手術風險，而消融被視為更安全、更有效的解決方案。為了因應醫療環境的這些變化，對消融設備的需求持續成長。

限制全球消融設備市場的因素

全球消融設備市場面臨的一大障礙是部署、維護和營運這些先進系統所帶來的沉重經濟負擔。先進消融技術（例如機器人輔助和人工智慧整合平台）所需的初始投資往往高得令人望而卻步，限制了小規模醫療機構（尤其是在中低收入地區）獲得這些技術的機會。此外，手術過程中產生的相關費用，例如一次性耗材、麻醉和術後護理，也會進一步加重本已捉襟見肘的醫療預算。這種經濟障礙有可能阻礙創新消融解決方案在各種醫療機構中的廣泛應用。

全球消融設備市場趨勢

全球消融設備市場正呈現出一股顯著的趨勢，即整合人工智慧（AI）技術以提高消融手術的精準度和效率。人工智慧技術正被應用於消融系統，實現即時影像分析、自動病灶檢測和個人化治療方案製定。這些先進工具使臨床醫生能夠輕鬆區分癌變組織和正常組織，從而更快、更準確地做出術中決策。透過最佳化消融過程中的能量輸出並預測手術結果，人工智慧不僅可以最大限度地減少併發症，還能提高長期成功率。這將革新患者照護，並鞏固其在不斷發展的消融治療領域中的關鍵作用。

Medtronic（Ireland）
Boston Scientific Corporation（USA）
Abbott Laboratories（USA）
Johnson & Johnson（USA）
AngioDynamics, Inc.（USA）
AtriCure, Inc.（USA）
Olympus Corporation（Japan）
Smith & Nephew plc（UK）
Stryker Corporation（USA）
Avanos Medical, Inc.（USA）
Hologic, Inc.（USA）
Becton, Dickinson and Company（USA）
Koninklijke Philips NV（Netherlands）
Baylis Medical Company, Inc.（Canada）
Elekta AB（Sweden）
Haifu Medical Technology Co., Ltd.（China）
Apyx Medical（formerly Bovie Medical）（USA）
LeMaitre Vascular, Inc.（USA）
Alcon Laboratories, Inc.（USA）
Biotronik SE & Co. KG（Germany）

結論與建議

簡介目錄

Product Code: SQMIG35A2603

Global Ablation Devices Market size was valued at USD 10.42 Billion in 2024 and is poised to grow from USD 11.56 Billion in 2025 to USD 26.44 Billion by 2033, growing at a CAGR of 10.9% in the forecast period (2026-2033).

The global ablation devices market is experiencing significant growth driven by heightened demand for minimally invasive procedures along with the rising incidence of chronic conditions such as cancer and cardiovascular diseases. These versatile devices find applications in various medical fields including cardiology, oncology, gynecology, and urology, thereby enhancing market reach. Continuous advancements in ablation technologies like radiofrequency, microwave, cryoablation, and lasers are improving procedural efficiency and patient outcomes, leading to quicker recoveries and reduced complications compared to traditional surgeries. Moreover, enhancements in healthcare infrastructure, increased spending, and greater patient awareness of innovative treatment options are propelling market development. However, high costs of equipment and procedures remain a challenge, particularly for smaller healthcare facilities in emerging markets, limiting broader adoption.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ablation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ablation Devices Market Segments Analysis

The ablation devices market is segmented into technology, application, end-user and region. Based on technology, the market is segmented into radiofrequency devices, laser/light ablation, ultrasound devices, cryoablation devices and other technologies. Based on application, the market is segmented into cardiology, oncology, ophthalmology, gynecology, urology,cosmetic surgeryand other applications. Based on end-user, the market is segmented into hospitals, ambulatory surgical centers and other end users. Based on region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Driver of the Global Ablation Devices Market

The increasing prevalence of chronic illnesses, including cancer, cardiovascular diseases, and neurological disorders, significantly propels the growth of the global ablation devices market. As patients and healthcare providers lean towards non-invasive and minimally invasive treatment options, the use of ablation techniques to manage conditions such as atrial fibrillation, liver tumors, and spinal disorders is on the rise. This trend is particularly pronounced among older adults, who often face heightened surgical risks; thus, ablation emerges as a safer and more efficient solution. Consequently, the demand for ablation devices continues to expand in response to these evolving healthcare dynamics.

Restraints in the Global Ablation Devices Market

A significant obstacle within the global ablation devices market is the considerable financial burden linked to the acquisition, upkeep, and operation of these sophisticated systems. The initial capital required for advanced ablation technology, such as robotic-assisted or AI-integrated platforms, is often prohibitively high, limiting access for smaller healthcare facilities, particularly in low- and middle-income regions. Furthermore, associated costs incurred during procedures, such as disposable materials, anesthesia, and post-operative care, can place additional strain on already constrained healthcare budgets. This financial barrier may hinder the widespread adoption of innovative ablation solutions in various healthcare settings.

Market Trends of the Global Ablation Devices Market

The Global Ablation Devices market is witnessing a significant trend towards the integration of Artificial Intelligence (AI) to enhance precision and efficiency in ablation procedures. AI technologies are being incorporated into ablation systems, enabling real-time imaging analysis, automatic lesion detection, and personalized treatment planning. These advanced tools empower clinicians to make quicker and more accurate intraoperative decisions, distinguishing cancerous tissues from healthy ones seamlessly. By optimizing energy delivery during ablation and predicting procedural outcomes, AI not only minimizes complications but also boosts long-term success rates, ultimately transforming patient care and solidifying its pivotal role in the evolving landscape of ablation therapies.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis

Global Ablation Devices Market Size by Technology & CAGR (2026-2033)

Market Overview
Radiofrequency devices
Laser/light ablation
Ultrasound devices
Cryoablation devices
Other technologies

Global Ablation Devices Market Size by Application & CAGR (2026-2033)

Market Overview
Cardiology
Oncology
Ophthalmology
Gynecology
Urology
Cosmetic surgery
Other applications

Global Ablation Devices Market Size by End-user & CAGR (2026-2033)

Market Overview
Hospitals
Ambulatory surgical centers
Other end users

Global Ablation Devices Market Size & CAGR (2026-2033)

North America (Technology, Application, End-user)
- US
- Canada
Europe (Technology, Application, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Application, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Application, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Application, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AtriCure, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avanos Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baylis Medical Company, Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elekta AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haifu Medical Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Apyx Medical (formerly Bovie Medical) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LeMaitre Vascular, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alcon Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments